Literature DB >> 16832697

[Evidence basis of psychotherapy for schizophrenia patients in Germany].

B Puschner1, R Vauth, F Jacobi, T Becker.   

Abstract

BACKGROUND: Little is known about the degree of implementation of evidence-based psychotherapy in routine care of people with schizophrenia in Germany.
METHOD: First, results of studies on the efficacy of psychotherapy in the treatment of schizophrenia are summarised. Second, the degree of implementation of psychotherapeutic practices in the routine care of schizophrenics is assessed through a systematic literature search and analyses of several data sets.
RESULTS: There is substantial evidence for the efficacy of cognitive-behavioural interventions in the treatment of schizophrenia. The paucity of data on the degree of implementation suggests a wide gap between evidence and practice.
CONCLUSIONS: Barriers to implementation are outlined and discussed. There is a need for more studies on epidemiological and long-term effectiveness of health care.

Entities:  

Mesh:

Year:  2006        PMID: 16832697     DOI: 10.1007/s00115-006-2102-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  53 in total

Review 1.  Interventions to improve medication adherence in schizophrenia.

Authors:  Annette Zygmunt; Mark Olfson; Carol A Boyer; David Mechanic
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

Review 2.  A review of cognitive training in schizophrenia.

Authors:  Elizabeth W Twamley; Dilip V Jeste; Alan S Bellack
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

Review 3.  Supportive therapy for schizophrenia: possible mechanisms and implications for adjunctive psychosocial treatments.

Authors:  David L Penn; Kim T Mueser; Nick Tarrier; Andrew Gloege; Corrine Cather; Daniel Serrano; Michael W Otto
Journal:  Schizophr Bull       Date:  2004       Impact factor: 9.306

Review 4.  [Effects of interventions to improve compliance with antipsychotic medication in people suffering from schizophrenia-results of recent reviews].

Authors:  Bernd Puschner; Anja Born; Anne Giessler; Hedda Helm; Thomas Becker; Matthias C Angermeyer
Journal:  Psychiatr Prax       Date:  2005-03

Review 5.  Clinical interventions for treatment non-adherence in psychosis: meta-analysis.

Authors:  Michela Nosé; Corrado Barbui; Richard Gray; Michele Tansella
Journal:  Br J Psychiatry       Date:  2003-09       Impact factor: 9.319

Review 6.  Treatment of the psychotic patient who is violent.

Authors:  Peter F Buckley; Stephen G Noffsinger; Douglas A Smith; Debra R Hrouda; James L Knoll
Journal:  Psychiatr Clin North Am       Date:  2003-03

7.  Cognitive approach to depression and suicidal thinking in psychosis. 1. Ontogeny of post-psychotic depression.

Authors:  M Birchwood; Z Iqbal; P Chadwick; P Trower
Journal:  Br J Psychiatry       Date:  2000-12       Impact factor: 9.319

Review 8.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 9.  Cognitive-behavioral therapy for schizophrenia: a review.

Authors:  Douglas Turkington; Robert Dudley; Debbie M Warman; Aaron T Beck
Journal:  J Psychiatr Pract       Date:  2004-01       Impact factor: 1.325

10.  Role of psychosocial treatments in management of schizophrenia: a meta-analytic review of controlled outcome studies.

Authors:  R Mojtabai; R A Nicholson; B N Carpenter
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

View more
  2 in total

1.  [Implementation of the recommendations for psychotherapy after psychiatric inpatient treatment : Results of the PAKT study Part II].

Authors:  C Uhlmann; E Flammer; C Pfiffner; J Grempler; G Längle; G-W Eschweiler; H Spießl; T Steinert
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

2.  The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis.

Authors:  Steffen Moritz; Fabrice Berna; Susanne Jaeger; Stefan Westermann; Matthias Nagel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-05-18       Impact factor: 5.270

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.